A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate Cancer

NCT01890096 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

174

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma of the Prostate

Interventions

RADIATION: HDR 2 Fraction
RADIATION: HDR 1 Fraction

Sponsor

Sunnybrook Health Sciences Centre